Results 61 to 70 of about 12,125 (226)
Platelet integrin αIIbβ3 plays a key role in a venous thrombogenesis mouse model
Venous thrombosis (VT) is a common vascular disease associated with reduced survival and a high recurrence rate. VT is initiated by the accumulation of platelets and neutrophils at sites of endothelial cell activation. A role for platelet αIIbβ3 in VT is
Brian D. Adair +14 more
doaj +1 more source
RACIONAL: A lesão de isquemia e reperfusão hepática é um evento comum e responsável por considerável morbidade e mortalidade. OBJETIVO: Avaliar efeitos de inibidor da glicoproteína IIb/IIIa, cloridrato de tirofiban, nas alterações hepáticas e pulmonares ...
Leonardo F. Canedo +5 more
doaj +1 more source
ABSTRACT Background Despite recommendations in international guidelines, Intracoronary pressure wire assessment (PWA) utilization remains limited in clinical practice. This study aims to describe (i) trends of PWA during Percutaneous coronary interventional (PCI), (ii) factors that predict its application, and (iii) association with in‐hospital ...
Hussein Bashar +3 more
wiley +1 more source
Case report: reuse of tirofiban leads to very severe thrombocytopenia
BackgroundTelofiban is a class of small molecule non-peptide tyrosine derivatives containing RGD sequences. It is the only platelet surface glycoprotein (GP) IIb/IIIa receptor antagonist (GPI) currently marketed in China.
Yuqing Li +3 more
doaj +1 more source
Tirofiban-induced thrombocytopenia
Tirofiban is a small non-peptide ligand-mimetic Glycoprotein (GP) IIb/IIIa inhibitor which can reversibly bind to the arginine-glycine-aspartic acid (RGD) recognition site of GP IIb/IIIa to prevent platelet aggregation.
Jun Wang, Dongna Zou
semanticscholar +1 more source
Association between tirofiban monotherapy and efficacy and safety in acute ischemic stroke
Background Studies have suggested that glycoprotein IIb/IIIa antagonists such as tirofiban are beneficial for patients with acute coronary syndromes.
Chunrong Tao +11 more
doaj +1 more source
IntroductionThe safety and efficacy of tirofiban in intravenous thrombolysis (IVT) bridging to mechanical thrombectomy in patients with acute ischemic stroke (AIS) is unknown.
Wei Li +13 more
doaj +1 more source
To evaluate the safety and efficacy of tirofiban in the treatment of acute ischemic stroke (AIS). Clinical data of 152 AIS patients with small vessel occlusion admitted in 2023 were retrospectively analyzed.
Qian Yang +4 more
semanticscholar +1 more source
BACKGROUND About 30 % of stroke patients have experienced unsuccessful reperfusion following endovascular therapy. Mechanical thrombectomy instruments may contribute to this by stimulating platelet aggregation.
M. M. Al-Salihi +8 more
semanticscholar +1 more source
(A). Forest plot for TVR based on a fixed-effects model in ACS patients treated with IC vs. IV administration of tirofiban. (B). Forest plot for death based on a fixed-effects model in ACS patients treated with IC vs. IV administration of tirofiban. (C).
Peng Liu (120506) +4 more
core +1 more source

